Preclinical Development of Enterobacter ludwigii LS57, a Human-Derived Swarming Strain, as a Live Biotherapeutic Product for Inflammatory Bowel Disease
Weijie Chen, Chaoyu Zhu, Yushan Guo…·Lei Liu
This paper reports the preclinical development of Enterobacter ludwigii LS57 as a safe, effective, and scalable live biotherapeutic product for inflammatory bowel disease.